OverviewSuggest Edit

Bioheng (also known as Nanjing Beiheng Biotech, 北恒生物) is a biopharmaceutical company that focuses on immunotherapy and gene therapy for treating cancer. It also provides a range of contract research services, including target screening and verification, pre-clinical studies, quality management, CRISPR-CAS9 gene editing, etc.
HQNanjing, CN


Bioheng is headquartered in
Nanjing, China

Location Map

Latest Updates

Cybersecurity ratingAMore

Bioheng Office Locations

Bioheng has an office in Nanjing
Nanjing, CN (HQ)
Pukou District
Show all (1)

Bioheng Financials and Metrics

Summary Metrics

Founding Date


Bioheng total Funding

$14.8 m

Bioheng latest funding size

$14.78 m

Time since last funding

2 years ago

Bioheng investors

Bioheng's latest funding round in February 2019 was reported to be $14.8 m. In total, Bioheng has raised $14.8 m
Show all financial metrics

Bioheng Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Bioheng Online and Social Media Presence

Embed Graph

Bioheng Frequently Asked Questions

  • When was Bioheng founded?

    Bioheng was founded in 2017.

  • Who are Bioheng competitors?

    Competitors of Bioheng include Aptus Clinical, Stamford Pharmaceuticals and Hubro Therapeutics.

  • Where is Bioheng headquarters?

    Bioheng headquarters is located at Pukou District, Nanjing.

  • Where are Bioheng offices?

    Bioheng has an office in Nanjing.

  • How many offices does Bioheng have?

    Bioheng has 1 office.